Search

Your search keyword '"Systemic scleroderma -- Patient outcomes"' showing total 36 results
Start Over Descriptor "Systemic scleroderma -- Patient outcomes"
36 results on '"Systemic scleroderma -- Patient outcomes"'

1. Data on Rheumatology Reported by a Researcher at University of Michigan (Improving outcomes in scleroderma: recent progress of cell-based therapies)

Subjects
Biochemistry -- Reports, Systemic scleroderma -- Patient outcomes, Scleroderma (Disease) -- Patient outcomes, Physical fitness -- Reports, Health
Abstract

2022 DEC 3 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on rheumatology are discussed in a new report. According to [...]

Published
2022

2. Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis

Author

Rigamonti, C., Shand, L.M., Feudjo, M., Bunn, C.C., Black, C.M., Denton, C.P., and Burroughs, A.K.

Subjects
Biliary cirrhosis -- Development and progression, Biliary cirrhosis -- Patient outcomes, Scleroderma (Disease) -- Complications and side effects, Scleroderma (Disease) -- Patient outcomes, Systemic scleroderma -- Complications and side effects, Systemic scleroderma -- Patient outcomes, Health
Published
2006

3. Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis

Author

Krause, Lijana, Becker, Mike O., Brueckner, Claudia S., Bellinghausen, Christina-Julia, Becker, Corinna, Schneider, Udo, Haeupl, Thomas, Hanke, Katharina, Hensel-Wiegel, Karin, Ebert, Heidrun, Ziemer, Sabine, Ladner, Ulf-Muller, Pirlich, Matthias, Burmester, Gerd R., and Riemekasten, Gabriela

Subjects
Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Research, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Research, Malnutrition -- Demographic aspects, Malnutrition -- Research, Outcome and process assessment (Health Care) -- Research, Impedance, Bioelectric -- Research, Body mass index -- Research, Health
Published
2010

4. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

Author

Tyndall, Anthony J., Bannert, Bettina, Vonk, Madelon, Airo, Paolo, Cozzi, Franco, Carreira, Patricia E., Bancel, Dominique Farge, Allanore, Yannick, Muller-Ladner, Ulf, Distler, Oliver, Iannone, Florenzo, Pellerito, Raffaele, Pileckyte, Margarita, Miniati, Irene, Ananieva, Lidia, Gurman, Alexandra Balbir, Damjanov, Nemanja, Mueller, Adelheid, Valentini, Gabriele, Riemekasten, Gabriela, Tikly, Mohammed, Hummers, Laura, Henriques, Maria J.S., Caramaschi, Paola, Scheja, Agneta, Rozman, Blaz, Ton, Evelien, Kumanovics, Gabor, Coleiro, Bernard, Feierl, Eva, Szucs, Gabriella, Von Muhlen, Carlos Alberto, Riccieri, Valeria, Novak, Srdan, Chizzolini, Carlo, Kotulska, Anna, Denton, Christopher, Coelho, Paulo C., Kotter, Ina, Simsek, Ismail, de la Pena Lefebvre, Paloma Garcia, Hachulla, Eric, Seibold, James R., Rednic, Simona, Stork, Jiri, Morovic-Vergles, Jadranka, and Walker, Ulrich A.

Subjects
Scleroderma (Disease) -- Causes of, Scleroderma (Disease) -- Risk factors, Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Research, Systemic scleroderma -- Causes of, Systemic scleroderma -- Risk factors, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Research, Mortality -- Switzerland, Mortality -- Demographic aspects, Mortality -- Research, Health
Published
2010

5. Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group

Author

Avouac, Jerome, Kowal-Bielecka, Otylia, Pittrow, David, Huscher, Doerte, Behrens, Frank, Denton, Christopher P., Foeldvari, Ivan, Humbert, Marc, Matucci-Cerinic, Marco, Nash, Peter, Opitz, Christian F., Rubin, Lewis J., Seibold, James R., Distler, Oliver, and Furst, Daniel E.

Subjects
Pulmonary hypertension -- Diagnosis, Pulmonary hypertension -- Patient outcomes, Pulmonary hypertension -- Research, Scleroderma (Disease) -- Diagnosis, Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Research, Systemic scleroderma -- Diagnosis, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Research, Exercise tests -- Usage, Exercise tests -- Research, Outcome and process assessment (Health Care) -- Methods, Outcome and process assessment (Health Care) -- Research, Health
Published
2010

6. Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study

Author

Smith, Vanessa, Pizzomi, Carmen, De Keyser, Filip, Decuman, Saskia, Van Praet, Jens T., Deschepper, Ellen, Sulli, Alberto, and Cutolo, Maurizio

Subjects
Scleroderma (Disease) -- Care and treatment, Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Research, Systemic scleroderma -- Care and treatment, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Research, Diagnostic imaging -- Methods, Diagnostic imaging -- Usage, Diagnostic imaging -- Research, Health
Published
2010

7. Severe fibrotic changes and altered expression of angiogenic factors in maternal scleroderma: placental findings

Author

Ibba-Manneschi, L., Manetti, M., Milia, A.F., Miniati, I., Benelli, G., Guiducci, S., Mecacci, F., Mello, G., Di Lollo, S., and Matucci-Cerinic, M.

Subjects
Scleroderma (Disease) -- Development and progression, Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Research, Systemic scleroderma -- Development and progression, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Research, Angiogenin -- Identification and classification, Angiogenin -- Physiological aspects, Angiogenin -- Research, Placenta -- Physiological aspects, Placenta -- Research, Fibroblasts -- Physiological aspects, Fibroblasts -- Research, Health
Published
2010

8. Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis

Author

Mouthon, L., Mestre-Stanislas, C., Berezne, A., Rannou, F., Guilpain, P., Revel, M., Pagnoux, C., Guillevin, L., Fermanian, J., and Poiraudeau, S.

Subjects
Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Physiological aspects, Scleroderma (Disease) -- Research, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Physiological aspects, Systemic scleroderma -- Research, Quality of life -- Health aspects, Quality of life -- Research, Fingers -- Injuries, Fingers -- Influence, Fingers -- Research, Skin -- Ulcers, Skin -- Influence, Skin -- Research, Health
Published
2010

9. A descriptive and prognostic study of systemic sclerosis-associated myopathies

Author

Ranque, B., Authier, F.-J., Le-Guern, V., Pagnoux, C., Berezne, A., Allanore, Y., Launay, D., Hachulla, E., Kahan, A., Cabane, J., Gherardi, R., Guillevin, L., and Mouthon, L.

Subjects
Scleroderma (Disease) -- Care and treatment, Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Research, Systemic scleroderma -- Care and treatment, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Research, Muscle diseases -- Complications and side effects, Muscle diseases -- Patient outcomes, Muscle diseases -- Research, Creatine kinase -- Analysis, Health
Published
2009

10. Exercise peripheral oxygen saturation (SpO2) accurately reflects arterial oxygen saturation (Sao2) and predicts mortality in systemic sclerosis

Author

Swigris, J.J., Zhou, X., Wamboldt, F.S., du Bois, R., Keith, R., Fischer, A., Cosgrove, G.P., Frankel, S.K., Curran-Everett, D., and Brown, K.K.

Subjects
Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Research, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Research, Lung diseases, Interstitial -- Patient outcomes, Lung diseases, Interstitial -- Research, Mortality -- United States, Mortality -- Research, Exercise tests -- Research, Pulmonary function tests -- Research, Health
Published
2009

11. European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research

Author

Avouac, J., Kowal-Bielecka, O., Landewe, R., Chwiesko, S., Miniati, I., Czirjak, L., Clements, P., Denton, C., Farge, D., Fligelstone, K., Foldvari, I., Furst, D.E., Muller-Ladner, U., Seibold, J., Silver, R.M., Takehara, K., Toth, B. Garay, Tyndall, A., Valentini, G., van den Hoogen, F., Wigley, F., Zulian, F., and Matucci-Cerinic, M.

Subjects
Scleroderma (Disease) -- Care and treatment, Scleroderma (Disease) -- Patient outcomes, Systemic scleroderma -- Care and treatment, Systemic scleroderma -- Patient outcomes, Delphi technique -- Usage, Clinical trials -- Evaluation, Practice guidelines (Medicine) -- Usage, Health
Published
2009

12. Extracorporeal photochemotherapy for generalized deep morphea

Author

Neustadter, Jason H., Samarin, Frank, Carlson, Kacie R., and Girardi, Michael

Subjects
Scleroderma (Disease) -- Care and treatment, Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Case studies, Systemic scleroderma -- Care and treatment, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Case studies, Photochemotherapy -- Usage, Photochemotherapy -- Patient outcomes, Photochemotherapy -- Case studies, Cancer -- Photochemotherapy, Cancer -- Usage, Cancer -- Patient outcomes, Cancer -- Case studies, Health
Published
2009

13. Measurement of upper limb ulcers in patients with systemic sclerosis: reproducibility and correlation with pain, function, and quality of life

Author

Toffolo, Sandra Regina, Furtado, Rita Nely Vilar, Klein, Adriana, Watanabe, Sandra, Andrade, Luis Eduardo Coelho, and Natour, Jamil

Subjects
Scleroderma (Disease) -- Care and treatment, Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Research, Systemic scleroderma -- Care and treatment, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Research, Outcome and process assessment (Health Care) -- Methods, Outcome and process assessment (Health Care) -- Usage, Outcome and process assessment (Health Care) -- Research, Quality of life -- Research, Leg -- Ulcers, Leg -- Care and treatment, Leg -- Patient outcomes, Leg -- Research, Business, Business, international, General interest, News, opinion and commentary
Published
2008

14. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients

Author

Teixeira, L., Mouthon, L., Mahr, A., Berezne, A., Agard, C., Mehrenberger, M., Noel, L.-H., Trolliet, P., Frances, C., Cabane, J., and Guillevin, L.

Subjects
Scleroderma (Disease) -- Complications and side effects, Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Research, Systemic scleroderma -- Complications and side effects, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Research, Corticosteroids -- Complications and side effects, Kidney failure -- Risk factors, Kidney failure -- Patient outcomes, Health
Published
2008

15. Can CCL2 serum levels be used in risk stratification or to monitor treatmen tresponse in systemic sclerosis?

Author

Carulli, M.T., Handler, C., Coghlan, J.G., Black, C.M., and Denton, C.P.

Subjects
Biological markers -- Research, Scleroderma (Disease) -- Care and treatment, Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Risk factors, Systemic scleroderma -- Care and treatment, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Risk factors, Chemokines -- Research, Chemokines -- Measurement, Health
Published
2008

16. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis

Author

Vonk, M.C., Marjanovic, Z., Van Den Hoogen, F.H.J., Zohar, S., Schattenberg, A.V.M.B., Fibbe, W.E., Larghero, J., Gluckman, E., van Laar, J.M., Farge, D., Preijers, F.W.M.B., van Dijk, A.P.J., Bax, J.J., Roblot, P., and van Riel, P.L.C.M.

Subjects
Scleroderma (Disease) -- Care and treatment, Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Research, Systemic scleroderma -- Care and treatment, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Research, Autografts -- Patient outcomes, Autografts -- Research, Hematopoietic stem cells -- Transplantation, Hematopoietic stem cells -- Patient outcomes, Hematopoietic stem cells -- Research, Health
Published
2008

17. Survival and causes of death in 366 Hungarian patients with systemic sclerosis

Author

Czirjak, L ., Kumanovics, G., Varju, C., Nagy, Z, Pakozdi, A., Szekanecz, Z., and Szucs, G.

Subjects
Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Research, Scleroderma (Disease) -- Demographic aspects, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Research, Systemic scleroderma -- Demographic aspects, Death -- Causes of, Health
Published
2008

18. Data on Rheumatic Diseases and Conditions Published by Researchers at Sanjay Gandhi Postgraduate Institute of Medical Sciences (Outcome of Pregnancy in Less Common Rheumatic Diseases: Inflammatory Myositis, Systemic Sclerosis and Vasculitis)

Subjects
Systemic scleroderma -- Patient outcomes, Medical research -- Reports, Medicine, Experimental -- Reports, Scleroderma (Disease) -- Patient outcomes, Pregnant women -- Patient outcomes, Health
Abstract

2021 JUL 16 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New research on rheumatic diseases and conditions is the subject of a new [...]

Published
2021

19. Changes in causes of death in systemic sclerosis, 1972-2002

Author

Steen, Virginia D. and Medsger, Thomas A.

Subjects
Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Forecasts and trends, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Forecasts and trends, Mortality -- Causes of, Mortality -- Forecasts and trends, Market trend/market analysis, Health
Published
2007

20. Systemic sclerosis associated pulmonary hypertension: improved survival in the current era

Author

Williams, M.H., Das, C., Handler, C.E., Akram, M.R., Davar, J., Denton, C.P., Smith, C.J., Black, C.M., and Coghlan, J.G.

Subjects
Pulmonary hypertension -- Research, Pulmonary hypertension -- Care and treatment, Pulmonary hypertension -- Patient outcomes, Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Care and treatment, Scleroderma (Disease) -- Research, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Care and treatment, Systemic scleroderma -- Research, Health
Published
2006

21. Autologous stem cell transplantation in the treatment of systemic sclerosis: Report from the EBMT/EULAR Registry

Author

Farge, D., Passweg, J., Laar, J.M. van, Marjanovic, Z., Besenthal, C., Finke, J., Peter, H.H., Breedveld, F.C., Fibbe, W.E., Black, C., Denton, C., Koetter, I., Locatelli, F., Martini, A., Schattenberg, A.V.N., Hoogen, F. van den, Putte, L. van de, Lanza, F., Arnold, R., Bacon, P.A., Bingham, S., Ciceri, F., Didier, B., Diez-Martin, J.L., Emery, P., Feremans, W., Hertenstein, B., Hiepe, F., Luosujarvi, R., Lara, A. Leon, Marmont, A., Martinez, A.M., Cascon, H. Pascual, Bocelli-Tyndall, C., Gluckman, E., Gratwohl, A., and Tyndall, A.

Subjects
Scleroderma (Disease) -- Patient outcomes, Systemic scleroderma -- Patient outcomes, Stem cells -- Transplantation, Stem cells -- Patient outcomes, Stem cells -- Analysis, Health
Published
2004

22. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis *. (clinical investigations)

Author

Kawut, Steven M., Taichman, Darren B., Archer-Chicko, Christine L., Palevsky, Harold I., and Kimmel, Stephen E.

Subjects
Systemic scleroderma -- Patient outcomes, Mortality -- United States, Scleroderma (Disease) -- Patient outcomes, Pulmonary hypertension -- Patient outcomes, Health, Patient outcomes
Abstract

Study objectives: The goal of this study was to determine whether the survival of patients with pulmonary hypertension related to systemic sclerosis (SScPH) was different from that of patients with [...]

Published
2003

24. Mortality and causes of death in a Swedish series of systemic sclerosis patients

Author

Hesselstrand, Roger, Scheja, Agneta, and Akesson, Anita

Subjects
Systemic scleroderma -- Patient outcomes, Cyclophosphamide -- Adverse and side effects, Health
Abstract

Patients with systemic sclerosis (SSc) have a substantially higher rate of death than people in the general population, but oral cyclophosphamide does not appear to contribute to this excess mortality. SSc is an autoimmune connective tissue disease. Swedish researchers evaluated the progression of disease and mortality among 249 SSc patients over approximately 6 years. SSc patients had 4.6 times the risk of dying during the study period as the general population. Half of the deaths were from lung diseases such as pulmonary fibrosis, pulmonary hypertension, or lung cancer. Patients taking cyclophosphamide did not have a higher risk of fatal cancers.

Published
1998

25. Pansclerotic morphea in childhood: a case report

Author

Doede, T., Wollina, U., Hindermann, W., Schier, F., and Bondartschuk, M.

Subjects
Scleroderma (Disease) -- Case studies, Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Care and treatment, Systemic scleroderma -- Case studies, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Care and treatment, Children -- Diseases, Children -- Case studies, Children -- Patient outcomes, Children -- Care and treatment, Health
Abstract

Byline: T. Doede (1), U. Wollina (2), W. Hindermann (3), F. Schier (1), M. Bondartschuk (1) Keywords: Scleroderma; Morphea; Squamous cell carcinoma Abstract: Scleroderma can be differentiated into progressive systemic and circumscript forms. The extensive form with lethal outcome is known from case reports of children and adolescents. The present case report concerns a boy who died at 16 years of age. In the 5th year of life, he experienced weight loss and developed multiple, firm, partially atrophic plaques in the skin of the extremities. These plaques gradually became confluent and extended over the whole torso and head. Plaque ulceration resulted in massive mutilations to the body. Later the patient's cachexia worsened and he developed keratose, moderately differentiated squamous cell carcinoma of the right leg. The prognosis of pansclerotic morphea for children is worse than for adults. No successful therapy is known. Author Affiliation: (1) Abteilung Kinderchirurgie, Klinikum der FSU Jena, Bachstrasse 18, 07740, Jena, Germany (2) Klinik fur Dermatologie und Dermatologische Allergologie, Erfurter Strasse 35, 07740, Jena, Germany (3) Institut Pathologie, Klinikum der FSU Jena, Bachstrasse 18, 07740, Jena, Germany Article History: Accepted Date: 10/12/2002 Online Date: 21/06/2003

Published
2003

26. Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease

Author

Aschwanden, M., Daikeler, T., Jaeger, K.A., Thalhammer, C., Gratwohl, A., Matucci-Cerinic, M., and Tyndall, A.

Subjects
Scleroderma (Disease) -- Patient outcomes, Systemic scleroderma -- Patient outcomes, Immunosuppressive agents -- Dosage and administration, Microscopy, Medical -- Methods, Nails (Anatomy) -- Medical examination, Health
Published
2008

27. What does the clinician need to improve patient care in systemic sclerosis?

Author

Vonk, Madelon C., van den Hoogen, Frank H.J., van Riel, Piet L.C.M., and Valentini, Gabriele

Subjects
Scleroderma (Disease) -- Diagnosis, Scleroderma (Disease) -- Care and treatment, Scleroderma (Disease) -- Patient outcomes, Systemic scleroderma -- Diagnosis, Systemic scleroderma -- Care and treatment, Systemic scleroderma -- Patient outcomes, Physicians -- Practice, Patients -- Care and treatment, Patients -- Methods, Medical care -- Quality management, Medical care -- Evaluation, Health, American College of Rheumatology -- Standards
Published
2007

28. Authors' reply

Author

Sardana, Kabir and Garg, V.

Subjects
Cyclophosphamide -- Dosage and administration, Cyclophosphamide -- Patient outcomes, Dexamethasone -- Dosage and administration, Dexamethasone -- Patient outcomes, Scleroderma (Disease) -- Drug therapy, Scleroderma (Disease) -- Patient outcomes, Systemic scleroderma -- Drug therapy, Systemic scleroderma -- Patient outcomes, Practice guidelines (Medicine)
Abstract

Byline: Kabir. Sardana, V. Garg Sir, We are thankful to the author[sup] [1],[2] for evincing interest in our article.[sup] [3] *Firstly we focused on newer approaches in scleroderma. Dexamethasone-cyclophosphamide pulse [...]

Published
2009

29. Birt-Hogg-Dube' syndrome

Author

Coplin, Rafael E.

Subjects
Genetic disorders -- Risk factors, Genetic disorders -- Diagnosis, Genetic disorders -- Care and treatment, Genetic disorders -- Patient outcomes, Genetic disorders -- Case studies, Scleroderma (Disease) -- Risk factors, Scleroderma (Disease) -- Diagnosis, Scleroderma (Disease) -- Care and treatment, Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Case studies, Systemic scleroderma -- Risk factors, Systemic scleroderma -- Diagnosis, Systemic scleroderma -- Care and treatment, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Case studies, Health
Abstract

Table of Contents Abstract Introduction Case Report Discussion References Abstract Birt-Hogg-Dube syndrome (BHD) is characterized by cutaneous manifestations specifically hair follicle tumors, renal neoplasms and pulmonary cysts. We will report [...]

Published
2008

30. Differences in disability as measured by the Health Assessment Questionnaire between patients with and without digital ulcers in systemic sclerosis: a post hoc analysis of pooled data from two randomised controlled trials in digital ulcers using bosentan

Author

Zelenietz, Caleb and Pope, Janet

Subjects
Varicose ulcer -- Patient outcomes, Varicose ulcer -- Research, Scleroderma (Disease) -- Care and treatment, Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Research, Systemic scleroderma -- Care and treatment, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Research, Disability -- Research, Outcome and process assessment (Health Care) -- Research, Bosentan -- Dosage and administration, Bosentan -- Research, Health
Published
2010

31. An evaluation of long-term outcomes in adults with pediatric-onset morphea

Author

Saxton-Daniels, Stephanie and Jacobe, Heidi T.

Subjects
Scleroderma (Disease) -- Development and progression, Scleroderma (Disease) -- Patient outcomes, Scleroderma (Disease) -- Demographic aspects, Scleroderma (Disease) -- Research, Systemic scleroderma -- Development and progression, Systemic scleroderma -- Patient outcomes, Systemic scleroderma -- Demographic aspects, Systemic scleroderma -- Research, Antinuclear antibodies -- Analysis, Fluorescent antibody technique -- Usage, Immunofluorescence -- Usage, Health
Published
2010

32. Ultrasonic massage and physical therapy for scleredema: improving activities of daily living

Author

Bray, Sarah M., Varghese, Shery, and English, Joseph C., III

Subjects
Scleroderma (Disease) -- Care and treatment, Scleroderma (Disease) -- Case studies, Scleroderma (Disease) -- Patient outcomes, Systemic scleroderma -- Care and treatment, Systemic scleroderma -- Case studies, Systemic scleroderma -- Patient outcomes, Massage -- Patient outcomes, Massage -- Case studies, Physical therapy -- Case studies, Therapeutics, Physiological -- Case studies, Activities of daily living -- Physiological aspects, Activities of daily living -- Management, Company business management, Health
Published
2010

33. Mycophenolate mofetil for cutaneous systemic sclerosis

Author

Heller, Marissa

Subjects
Scleroderma (Disease) -- Drug therapy, Scleroderma (Disease) -- Patient outcomes, Systemic scleroderma -- Drug therapy, Systemic scleroderma -- Patient outcomes, Health, Pharmaceuticals and cosmetics industries
Abstract

A recent retrospective analysis assessed the indications, duration, and tolerability of mycophenolate mofetil (MMF) as a therapy for diffuse cutaneous systemic sclerosis. Clinical outcomes were compared to a control cohort [...]

Published
2007

34. 'Light' stem cell transplants may benefit those with severe scleroderma

Subjects
Scleroderma (Disease) -- Care and treatment, Scleroderma (Disease) -- Patient outcomes, Systemic scleroderma -- Care and treatment, Systemic scleroderma -- Patient outcomes, Stem cells -- Transplantation, Stem cells -- Methods, Stem cells -- Patient outcomes, Health
Abstract

Preliminary research suggests that less-toxic stem cell transplants may benefit people with scleroderma, a devastating autoimmune disease that can cause skin blood vessels and internal organs to thicken and harden. [...]

Published
2007

35. Organ involvement reduces scleroderma survival

Author

Freeman, Sara

Subjects
Systemic scleroderma -- Patient outcomes, Medical research, Medicine, Experimental, Scleroderma (Disease) -- Patient outcomes, Health, Health care industry
Abstract

BRIGHTON, ENGLAND - Survival from scleroderma is improving, but major organ-based complications are still a significant reason for premature death, according to the results of a long-term outcomes study. The [...]

Published
2011

36. Sclerema neonatorum after therapeutic whole-body hypothermia

Author

Navarini-Meury, Susanne, Schneider, Jacques, and Buhrer, Christoph

Subjects
Hypothermia -- Complications and side effects, Asphyxia -- Development and progression, Asphyxia -- Care and treatment, Asphyxia -- Patient outcomes, Scleroderma (Disease) -- Risk factors, Scleroderma (Disease) -- Patient outcomes, Systemic scleroderma -- Risk factors, Systemic scleroderma -- Patient outcomes, Family and marriage, Health, Women's issues/gender studies
Published
2007

Catalog

Books, media, physical & digital resources
See catalog results